|
128 Companies |
|
121 Products |
|
121 Products |
|
104 Mechanisms of Action |
|
7 Trials |
|
1812 News |
|
| «12...910111213141516171819...3637» |
- Trial initiation date: Sensorimotor Dysfunction in Achalasia (clinicaltrials.gov) - Dec 17, 2015
P=N/A, N=50, Not yet recruiting, Sponsor: Mayo Clinic
Initiation date: May 2015 --> Jan 2016
- Clinical data, Trial initiation date: Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes (clinicaltrials.gov) - Dec 17, 2015
P=N/A, N=448, Not yet recruiting, Sponsor: Cedars-Sinai Medical Center
Initiation date: May 2015 --> Jan 2016 Initiation date: Sep 2015 --> Jan 2016
- New trial: Confocal Laser Endomicroscopy vs Conventional Histology for the Identification of Intestinal Metaplasia (clinicaltrials.gov) - Dec 17, 2015
P=N/A, N=200, Not yet recruiting, Sponsor: Minnesota Institute for Minimally Invasive Surgery
- | Enrollment closed, Surgery: Prevention of Post-operative Pneumonia (POPP) (clinicaltrials.gov) - Dec 16, 2015
P2/3, N=330, Active, not recruiting, Sponsor: Washington University School of Medicine
Initiation date: Sep 2015 --> Jan 2016 Recruiting --> Active, not recruiting
- |||| MM 111 / Elevation Oncology
Trial completion, Metastases: A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach (clinicaltrials.gov) - Dec 16, 2015
P2, N=120, Completed, Sponsor: Merrimack Pharmaceuticals
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Biomarker, Trial completion, Enrollment change, Trial primary completion date, FDG PET: FDG-PET-CT and Biomarkers in Esophageal Cancer (clinicaltrials.gov) - Dec 15, 2015
P=N/A, N=31, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=95 --> 31 | Trial primary completion date: Mar 2016 --> Dec 2015
- | Trial completion: Translation of the Sydney Swallow Questionnaire and Validation of the German Version (clinicaltrials.gov) - Dec 15, 2015
P=N/A, N=30, Completed, Sponsor: University of Zurich
Active, not recruiting --> Completed | N=95 --> 31 | Trial primary completion date: Mar 2016 --> Dec 2015 Active, not recruiting --> Completed
- Enrollment closed, Enrollment change: Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive (clinicaltrials.gov) - Dec 12, 2015
P=N/A, N=154, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=220 --> 154
- Aqupla (nedaplatin) / Simcere
Trial primary completion date, Metastases: Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma (clinicaltrials.gov) - Dec 11, 2015
P1/2, N=18, Recruiting, Sponsor: Chinese Academy of Medical Sciences
Recruiting --> Active, not recruiting | N=220 --> 154 Trial primary completion date: Oct 2015 --> Dec 2016
- New trial: ProdDiGYPark: Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease (clinicaltrials.gov) - Dec 11, 2015
P=N/A, N=64, Recruiting, Sponsor: University Hospital, Lille
- New trial: Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux Disease (clinicaltrials.gov) - Dec 11, 2015
P=N/A, N=160, Recruiting, Sponsor: Loren Laine
- Trial completion, Enrollment change: Laparoscopic Dor Versus Toupet Fundoplication for the Treatment of Idiopathic Esophageal Achalasia (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=60, Completed, Sponsor: L. Michael Brunt
Trial primary completion date: Oct 2015 --> Dec 2016 Active, not recruiting --> Completed | N=200 --> 60
- Trial primary completion date: Efficacy & Safety of Submucosal Endoscopic Myotomy With Mucosal Flap (SEMF) in the Treatment of Patients With Achalasia (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=100, Recruiting, Sponsor: Winthrop University Hospital
Active, not recruiting --> Completed | N=200 --> 60 Trial primary completion date: Feb 2014 --> Feb 2017
- Carafate (sucralfate) / AbbVie
Enrollment change, Trial withdrawal, Trial primary completion date: CE_NERD: Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD) (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=0, Withdrawn, Sponsor: Virginia Commonwealth University
Trial primary completion date: Feb 2014 --> Feb 2017 N=120 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Dec 2015
- New trial: VANTAGE: Valvuloplasty as Alternative to Toupet Fundoplication for GERD (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=160, Not yet recruiting, Sponsor: Meander Medical Center
- Trial withdrawal: Simultaneous Fluoroscopic and Endoscopic Examination of the Oropharyngeal Phase of Deglutition (clinicaltrials.gov) - Dec 9, 2015
P=N/A, N=0, Withdrawn, Sponsor: University of California, Davis
N=120 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2015 --> Dec 2015 Completed --> Withdrawn
- Enrollment closed: EoE(Eosinophilic Esophagitis) (clinicaltrials.gov) - Dec 9, 2015
P=N/A, N=10, Active, not recruiting, Sponsor: University of Michigan
Completed --> Withdrawn Recruiting --> Active, not recruiting
- Trial completion: Time Interval for Endoscopic Variceal Ligation (clinicaltrials.gov) - Dec 9, 2015
P4, N=90, Completed, Sponsor: University of Southern California
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: The Effect of Prophylactic Swallowing Exercises on Head and Neck Cancer Patients (clinicaltrials.gov) - Dec 6, 2015
P=N/A, N=26, Completed, Sponsor: Icahn School of Medicine at Mount Sinai
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jun 2012 --> Jan 2011
- evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
Trial primary completion date, Combination therapy: Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. (clinicaltrials.gov) - Dec 5, 2015
P1, N=18, Not yet recruiting, Sponsor: Maastricht Radiation Oncology
Active, not recruiting --> Completed | Trial primary completion date: Jun 2012 --> Jan 2011 Trial primary completion date: Dec 2016 --> Dec 2017
- |||||||||| New P3 trial: Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study (clinicaltrials.gov) - Dec 5, 2015
P3, N=644, Recruiting, Sponsor: Reckitt Benckiser Healthcare (UK) Limited
- Trial completion: Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection (clinicaltrials.gov) - Dec 5, 2015
P4, N=64, Completed, Sponsor: University Hospital, Linkoeping
Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed
- pemetrexed / Generic mfg., docetaxel / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date, Combination therapy, Metastases: Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Dec 5, 2015
P1, N=33, Completed, Sponsor: University of Arizona
Recruiting --> Completed Active, not recruiting --> Completed | N=54 --> 33 | Trial primary completion date: Apr 2014 --> Jul 2014
- Gastrocrom (cromolyn) / Viatris
Enrollment open, Trial primary completion date: Cromolyn Detection of Silent Aspiration (clinicaltrials.gov) - Dec 4, 2015
P1, N=15, Recruiting, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed | N=54 --> 33 | Trial primary completion date: Apr 2014 --> Jul 2014 Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2015 --> Apr 2016
- Avastin (bevacizumab) / Roche
Trial primary completion date: VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions (clinicaltrials.gov) - Dec 4, 2015
P1, N=10, Recruiting, Sponsor: University Medical Center Groningen
Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2015 --> Apr 2016 Trial primary completion date: May 2015 --> Jun 2016
- New trial, Bariatric surgery: Laparoscopic Roux-en-Y Gastric Bypass and Gastro-esophageal Reflux (clinicaltrials.gov) - Dec 3, 2015
P=N/A, N=86, Completed, Sponsor: University of Turin, Italy
- |||||||||| New P3 trial: Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients (clinicaltrials.gov) - Dec 3, 2015
P3, N=88, Recruiting, Sponsor: Reckitt Benckiser Healthcare (UK) Limited
- New trial: Influence of Intrapulmonary Percussive Ventilation (IPV) on Gastro-oesophageal Reflux (GOR). (clinicaltrials.gov) - Dec 3, 2015
P=N/A, N=50, Recruiting, Sponsor: Vrije Universiteit Brussel
- prednisone / Generic mfg.
Trial primary completion date: Reduction in Symptomatic Esophageal Stricture Formation (clinicaltrials.gov) - Nov 27, 2015
P4, N=126, Recruiting, Sponsor: Florida Hospital
Trial primary completion date: May 2015 --> Jun 2016 Trial primary completion date: Mar 2015 --> Mar 2017
- Trial completion, Trial primary completion date: OPMD: Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts (clinicaltrials.gov) - Nov 22, 2015
P2, N=30, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial primary completion date: Mar 2015 --> Mar 2017 Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jul 2015
- paclitaxel / Generic mfg.
Enrollment change, Trial withdrawal, Metastases: Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer (clinicaltrials.gov) - Nov 21, 2015
P3, N=0, Withdrawn, Sponsor: Shantou University Medical College
Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jul 2015 N=202 --> 0 | Recruiting --> Withdrawn
- || New P2/3 trial: Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids (clinicaltrials.gov) - Nov 21, 2015
P2/3, N=292, Not yet recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
- New trial, Tumor cell: ESO-CTC: Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC (clinicaltrials.gov) - Nov 21, 2015
P=N/A, N=20, Not yet recruiting, Sponsor: University Hospital Freiburg
- New P1 trial, Surgery: NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG (clinicaltrials.gov) - Nov 21, 2015
P1, N=200, Enrolling by invitation, Sponsor: Chinese Academy of Sciences
- oxaliplatin / Generic mfg., paclitaxel / Generic mfg.
New P2 trial, Metastases: CCRT for Esophageal Cancer. (clinicaltrials.gov) - Nov 18, 2015
P2, N=34, Completed, Sponsor: Hangzhou Cancer Hospital
- ||| New trial: Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease. (clinicaltrials.gov) - Nov 17, 2015
P=N/A, N=1000, Not yet recruiting, Sponsor: AstraZeneca
- Trial primary completion date: CT0046 Study: Balloon Dilation to Permit Complete Endoscopic Ultrasound Staging in Esophageal Cancer (clinicaltrials.gov) - Nov 17, 2015
P=N/A, N=40, Recruiting, Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
N=202 --> 0 | Recruiting --> Withdrawn Trial primary completion date: Jul 2015 --> Jan 2016
- New trial: Photoacoustic Endoscopy of Barrett's Esophagus (clinicaltrials.gov) - Nov 17, 2015
P0, N=30, Recruiting, Sponsor: Washington University School of Medicine
- | 5-fluorouracil / Generic mfg., cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Surgery: Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery (clinicaltrials.gov) - Nov 16, 2015
P2, N=0, Completed, Sponsor: Radiation Therapy Oncology Group
Trial primary completion date: Jul 2015 --> Jan 2016 No longer recruiting --> Completed
- sirolimus / Generic mfg.
Enrollment change: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (clinicaltrials.gov) - Nov 15, 2015
P1, N=30, Active, not recruiting, Sponsor: Roswell Park Cancer Institute
No longer recruiting --> Completed N=18 --> 30
- Enrollment closed: Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid (clinicaltrials.gov) - Nov 14, 2015
P=N/A, N=54, Active, not recruiting, Sponsor: University of Ottawa
N=18 --> 30 Not yet recruiting --> Active, not recruiting
- esomeprazole / Generic mfg.
Trial primary completion date: Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy (clinicaltrials.gov) - Nov 10, 2015
P4, N=500, Recruiting, Sponsor: Chang Gung Memorial Hospital
Not yet recruiting --> Active, not recruiting Trial primary completion date: Dec 2015 --> Jun 2016
- | evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
New P1 trial, Combination therapy: Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. (clinicaltrials.gov) - Nov 8, 2015
P1, N=18, Not yet recruiting, Sponsor: Maastricht Radiation Oncology
- Enrollment change, Trial withdrawal: Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation (clinicaltrials.gov) - Nov 3, 2015
P=N/A, N=0, Withdrawn, Sponsor: Showa Inan General Hospital
Trial primary completion date: Dec 2015 --> Jun 2016 N=20 --> 0 | Recruiting --> Withdrawn
- Trial completion: Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke (clinicaltrials.gov) - Nov 3, 2015
P4, N=62, Completed, Sponsor: Parc de Salut Mar
N=20 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed
- New trial: Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study (clinicaltrials.gov) - Nov 2, 2015
P=N/A, N=1000, Not yet recruiting, Sponsor: General Hospital of Shenyang Military Region
- New trial: Recurrent Respiratory Papillomatosis and Extraesophageal Reflux (clinicaltrials.gov) - Oct 30, 2015
P=N/A, N=60, Recruiting, Sponsor: University Hospital Ostrava
- Trial completion: Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer (clinicaltrials.gov) - Oct 29, 2015
P2, N=94, Completed, Sponsor: Barretos Cancer Hospital
Recruiting --> Completed Recruiting --> Completed
- irinotecan / Generic mfg., docetaxel / Generic mfg.
Trial primary completion date, Metastases: Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma (clinicaltrials.gov) - Oct 27, 2015
P2, N=40, Active, not recruiting, Sponsor: University of Southern California
Recruiting --> Completed Trial primary completion date: Jan 2015 --> Jun 2016
- 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., docetaxel / Generic mfg.
Trial completion, Trial primary completion date: Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma (clinicaltrials.gov) - Oct 27, 2015
P2, N=10, Completed, Sponsor: McGill University
Trial primary completion date: Jan 2015 --> Jun 2016 Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Jun 2015